expert roundtables

Multiple Sclerosis: Safety Profiles of Disease-Modifying Therapies

by Robert A. Bermel, MD, MBA; Malcolm H. Gottesman, MD; and Eric C. Klawiter, MD, MSc

The expansion of the multiple sclerosis (MS) treatment arsenal has led to more options for disease-modifying therapy (DMT) than ever before. Althou......READ MORE

LATEST IN EXPERT PERSPECTIVES

Browse More Articles